January 5, 2024 · Form 4 insider transaction
Oliver Tracie sold 74 shares of Arrowhead Pharmaceuticals, Inc. at $33.89 per share, a transaction worth $2.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.; Partial disposition of RSUs to satisfy tax withholding obligations.; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.